Tuesday, 31 March 2020

China News

  • Novozymes to help build bio-refinery in China

    China |  News | By BioSpectrum Bureau  | 0 Comment | 19 Nov, 2013

    Singapore: Europe-based Novozymes has partnered with M&G Chemicals to supply enzyme technology for glycols bio-refinery to be constructed in China. The bio-refinery will be located in ...Read more

  • Medtronic, LifeTech alliance to serve heart patients

    China |  News | By BioSpectrum Bureau  | 0 Comment | 18 Oct, 2012

    Singapore: Medtronic and LifeTech Scientific have entered into a strategic alliance to serve cardiovascular patients and clinicians, who had previously been unreachable and to develop a mo...Read more

  • 3SBio posts 31% revenue growth in Q2 2012

    China |  Company results | By BioSpectrum Bureau  | 0 Comment | 15 Aug, 2012

    Singapore: 3SBio, a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, has announced its unaudited financi...Read more

  • ActiViews gets SFDA nod for needle guidance system

    China |  News | By BioSpectrum Bureau  | 0 Comment | 23 May, 2012

    Singapore: ActiViews, a company pioneering the development of simple, accurate, and cost-effective surgical navigation solutions, received clearance to market CT-Guide navigation for minima...Read more

  • Swedish radiation therapy solution gets CFDA nod

    China |  Analysis | By BioSpectrum Bureau  | 0 Comment | 14 Aug, 2013

    Singapore: Swedish medical technology company RaySearch Laboratories that develops advanced software solutions for improved radiation therapy of cancer has received China FDA (CFDA) approva...Read more

  • Novartis posts 20 percent rise in Q1 profit

    China |  Company results | By BioSpectrum Bureau  | 0 Comment | 29 Apr, 2014

    Singapore: Novartis announced that it has recorded a 20 percent rise in its first-quarter profit. Reports said that the net profit attributable to shareholders climbed to $2.94 billion fro...Read more

  • Ventana gets CFDA nod for cancer antibody assay

    China |  News | By BioSpectrum Bureau  | 0 Comment | 12 Sep, 2013

    Singapore: Ventana Medical Systems, which is a member of the Roche Group, received approval for its Ventana ALK (D5F3) Rabbit Monoclonal Primary Antibody assay by the Chinese Food and Drug ...Read more

  • ShangPharma appoints committee chairman

    China |  News | By BioSpectrum Bureau  | 0 Comment | 18 Jul, 2012

    Singapore: ShangPharma, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, has appointed Mr Yuk Lam Lo as the chairman of the independent c...Read more

  • BGI study gives insight into human gut microbiota

    China |  News | By BioSpectrum Bureau  | 0 Comment | 27 Sep, 2012

    Singapore: A novel metagenomic study on human gut microbiota and their potential impact on type 2 diabetes, the most common form of diabetes, has been published by a team of BGI researchers...Read more

  • BioTime director passes away

    China |  Influencers | By BioSpectrum Bureau  | 0 Comment | 27 Nov, 2012

    Singapore: Mr Abraham (Barry) E Cohen, member of BioTime's board of directors, passed away at the age of 76. BioTime is a US-based company, focused on biomedical research and product develo...Read more

  • Dehaier develops portable oxygen inhaler

    China |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jun, 2012

    Singapore: Dehaier Medical Systems, an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, has co-developed "High-Eff...Read more

  • China SFDA drug lab gets WHO prequalification

    China |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 10 Jan, 2013

    Singapore: The World Health Organization (WHO) has included China's National Institutes for Food and Drug Control (NIFDC) to the list of prequalified quality control laboratories. This in...Read more

  • APAC stem cell therapy market to reach $972mn in 2018

    China |  News | By BioSpectrum Bureau  | 0 Comment | 01 Jan, 2013

    Singapore: A new study by Reports and Reports predicted that the stem cell therapy market in Asia Pacific (APAC) will grow in value from $545 million in 2012 to $972 million in 2018, at a c...Read more

  • BGI-Shenzhen gets clearnace from NDRC for BGI's acquisition

    China |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

    Singapore: BGI-Shenzhen and Complete Genomics have obtained clearance from the National Development and Reform Commission of the People's Republic of China regarding BGI's proposed acquisi...Read more

  • GSK CEO accompanies UK PM on China visit

    China |  News | By BioSpectrum Bureau  | 0 Comment | 02 Dec, 2013

    Singapore: After facing a storm of controversy in China, Sir (Dr) Andrew Witty, CEO, GlaxoSmithKline (GSK) visited the country accompanying UK Prime Minister Mr David Cameron on his trade m...Read more

  • How Chinese economy will impact its life sciences?

    China |  Opinion | By BioSpectrum Bureau  | 0 Comment | 13 Mar, 2013

    During a January 2013 economic forum in Beijing, Lou Jiwei, chairman of the China Investment Corporation (CIC), presented forecasts that China's economy could grow at more than eight percen...Read more

  • ShangPharma completes in-house merger

    China |  News | By BioSpectrum Bureau  | 0 Comment | 28 Mar, 2013

    Singapore: ShangPharma, a leading China-based pharmaceutical and biotechnology R&D outsourcing company, has completed the merger contemplated by the previously announced agreement and p...Read more

  • China CRO facility undergoes US FDA inspection

    China |  News | By BioSpectrum Bureau  | 0 Comment | 21 Mar, 2013

    Singapore: For the first time, the US FDA has completed an inspection in China under its combined clinical trial and bioresearch monitoring program. Frontage Laboratories, a pharmaceutical...Read more